Self-Efficacy Levels of Nurses on Safe Blood and Blood Product Transfusion

August 2, 2024 updated by: Arzu Bahar, Yuksek Ihtisas University

Investigation of Self-Efficacy Levels of Cardiovascular Surgery Intensive Care Unit Nurses on Safe Blood and Blood Product Transfusion

A quasi-experimental study was conducted in a pre-test-post-test design to investigate the self-efficacy levels of nurses working in a cardiovascular surgery Intensive Care Unit regarding safe blood and blood product transfusion and the effects of online training.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Blood transfusion is a life-saving and therapeutic procedure, but it also carries high risks. Nurses have the greatest responsibility in preventing complications related to blood transfusion. To maintain safe practice standards, healthcare institutions need to use national transfusion guidelines and establish blood banks/transfusion laboratories, transfusion protocols, and hemovigilance teams. From the moment the blood is collected from the donor to the end of the transfusion, administering the right blood to the right patient, storing the blood appropriately, monitoring the patient for signs of reactions during the procedure, and having sufficient knowledge and skills on precautions to be taken when complications develop are the responsibilities of nurses regarding transfusion. For nurses to fulfill their duties in this regard, they must have up-to-date knowledge, skills, and competence. Since CVS intensive care clinics are where blood transfusion is performed most frequently, it is of particular importance that the nurses working in these units have sufficient knowledge on the subject and are strengthened in this regard. Based on this situation, the research is planned to determine the self-sufficiency levels of nurses working in the CVS intensive care unit regarding blood transfusion and to contribute to the field by eliminating deficiencies in this regard through training.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Çankaya
      • Ankara, Çankaya, Turkey
        • Yuksek Ihtisas University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • volunteer nurses

Exclusion Criteria:

  • Nurses who did not want to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: online education
- Nurses' self-efficacy levels regarding safe blood transfusion practices will be measured with the Safe Blood and Blood Products Transfusion Self-Efficacy Scale (SBT-SES). SBT-SES pre-tests will be applied to the control and intervention groups, and online training on safe blood transfusion prepared by the researcher will be provided to the intervention group. After the training given to the intervention group, SBT-SES post-tests will be applied to both the intervention and control groups.
Other: online education
online education
No Intervention: control
No training will be given, only the Blood Products Transfusion Self-Efficacy Scale (SBT-SES) pre-test and post-test will be conducted.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Personal Information Form
Time Frame: 20 minutes
This form, prepared by researchers, includes a total of 13 questions that include nurses' personal and professional characteristics as well as their experiences with blood transfusion (age, gender, professional experience, education, having performed a transfusion, etc.).
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Products Transfusion Self-Efficacy Scale (SBT-SES)
Time Frame: 50 minutes
Blood and Blood Products Transfusion Self-Efficacy Scale contains 49 items. The 5-point Likert type scal. Behavioral Sub-Factor with 16 items; Cognitive Sub-Factor with 14 items; The Attitudinal Sub-Factor consists of 13 items; The Negative Sub-Factor consists of six items. The six items in the negative sub-dimension are reverse and should be reverse-coded during analysis. The minimum score that can be obtained from the total scale is 49 and the maximum score is 245. As the scores obtained from the entire scale and its sub-dimensions increase, it is evaluated that the self-efficacy of nurses for safe blood and blood product transfusion practices increases.
50 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yuksek Ihtisas University

Investigators

  • Principal Investigator: arzu bahar, Yuksek Ihtisas University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2024

Primary Completion (Actual)

July 20, 2024

Study Completion (Actual)

July 30, 2024

Study Registration Dates

First Submitted

August 2, 2024

First Submitted That Met QC Criteria

August 2, 2024

First Posted (Actual)

August 7, 2024

Study Record Updates

Last Update Posted (Actual)

August 7, 2024

Last Update Submitted That Met QC Criteria

August 2, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ABAHAR-003

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on To Evaluate the Effect of Online Education on Nurses' Self-efficacy Regarding Blood Transfusion

Clinical Trials on online education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe